iShares Health Innovation Active ETF · $14M$12,713
BMEDBMED vsPPHPPHVanEck Pharmaceutical ETF · $1.1B$18,329
$10,000 five years ago, dividends reinvested · they hold 13.5% in common
BMEDMeasurePPH
Returns · dividends reinvested
+23.3%Year to dateJan 1 → Nov 4+20.4%
+32.3%1 yearTotal return+34.2%
+21.9%3 years · per year$10,000 became $18,098 · $17,228+19.9%
+4.9%5 years · per year$10,000 became $12,713 · $18,329+12.9%
Cost and income
0.77%Expense ratio$77 · $36 a year on $10k · lower is better0.36%
0.22%Trailing 12-mo yield$22 · $175 a year on $10k1.75%
Risk · past year
−14.9%Worst dropSmaller is better−10.8%
17.9%VolatilityLower is calmer18.7%
BMEDPPH Winner of the row, in its colourEach row: the bigger of the two fills its side
3–5PPH wins
End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns